| Indoco Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532612 |
NSE Symbol : INDOCO |
P/E(TTM) : 107.02 |
|
ISIN Demat : INE873D01024 |
Div & Yield% : 0.08 |
EPS(TTM) : 2.33 |
|
Book Value(₹) : 119.08 |
Market Cap(₹Cr) : 2,301.59 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 408.12 | 429.06 | 389.57 | 429.30 | 385.61 | 341.07 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 408.12 | 429.06 | 389.57 | 429.30 | 385.61 | 341.07 |
| Other Operating Income | 0.85 | 20.07 | 10.94 | 12.82 | 8.70 | 6.18 |
| Other Income | 101.81 | 14.03 | 7.17 | 6.54 | 5.58 | 6.50 |
| Total Income | 510.78 | 463.16 | 407.68 | 448.66 | 399.89 | 353.75 |
| Total Expenditure | 366.76 | 386.10 | 380.62 | 389.26 | 379.49 | 343.79 |
| PBIDT | 144.02 | 77.06 | 27.06 | 59.40 | 20.40 | 9.96 |
| Interest | 22.75 | 22.73 | 20.15 | 22.01 | 23.61 | 15.98 |
| PBDT | 121.27 | 54.33 | 6.91 | 37.39 | -3.21 | -6.02 |
| Depreciation | 28.05 | 26.71 | 27.36 | 27.63 | 25.20 | 24.88 |
| Tax | 10.56 | 2.92 | 0.00 | 0.00 | 0.00 | -2.93 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.34 | -2.65 | -0.45 | -5.29 | -0.34 | -1.73 |
| Reported Profit After Tax | 82.32 | 27.35 | -20.00 | 15.05 | -28.07 | -26.24 |
| Extra-ordinary Items | 86.44 | 3.29 | -6.01 | -0.53 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -4.12 | 24.06 | -13.99 | 15.58 | -28.07 | -26.24 |
| EPS (Unit Curr.) | 8.92 | 2.96 | -2.17 | 1.63 | -3.04 | -2.85 |
| EPS (Adj) (Unit Curr.) | 8.92 | 2.96 | -2.17 | 1.63 | -3.04 | -2.85 |
| Calculated EPS (Unit Curr.) | 8.92 | 2.96 | -2.17 | 1.63 | -3.04 | -2.84 |
| Calculated EPS (Adj) (Unit Curr.) | 8.92 | 2.96 | -2.17 | 1.63 | -3.04 | -2.84 |
| Calculated EPS (Ann.) (Unit Curr.) | 35.67 | 11.85 | -8.67 | 6.53 | -12.17 | -11.38 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 35.67 | 11.85 | -8.67 | 6.53 | -12.17 | -11.38 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 18.46 | 18.46 | 18.45 | 18.45 | 18.45 | 18.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.29 | 17.96 | 6.95 | 13.84 | 5.29 | 2.92 |
| PBDTM(%) | 29.71 | 12.66 | 1.77 | 8.71 | -0.83 | -1.77 |
| PATM(%) | 20.17 | 6.37 | -5.13 | 3.51 | -7.28 | -7.69 |
